The Mount Sinai Hospital

They are legally distinct pools. The hospital endowment supports clinical operations and the flagship Mount Sinai Hospital campus, while the Icahn School of Medicine manages a separate endowment funding medical education and faculty research. Their investment offices operate independently, though both fall under the Mount Sinai Health System umbrella. An allocator evaluating either pool should treat them as unrelated counterparties.

Scott Pittman serves as Senior Vice President and Chief Investment Officer. He oversees the endowment portfolio and reports through the health system's finance leadership. The board of trustees, which includes Glenn Dubin and Ken Mehlman, provides investment-committee oversight and access to alternative-asset networks.

Yes. Mount Sinai has participated in direct venture investments and spinouts connected to its research enterprise. The institution's 2023 AI-centralization strategy suggests a pipeline for commercializing internally developed intellectual property. For external managers, the endowment allocates through traditional VC and growth-equity fund commitments rather than acting as a direct institutional venture investor at scale.

Unusually high for an academic medical center endowment. The institution directly owns commercial condominiums at 150 East 42nd Street, the Hess Center for Science and Medicine on Madison Avenue, and clinical space at 55 Hudson Yards. It also holds a residential portfolio on the Upper East Side and undeveloped land in Westchester, Florida. These are balance-sheet assets—not REIT holdings—making the endowment's total return partially correlated with New York commercial property values.

Both serve as trustees and bring considerable alternatives expertise. Dubin founded Highbridge Capital and has a long track record allocating to hedge funds. Mehlman is a member at KKR with visibility into large-scale private-equity deal flow. While neither is involved in day-to-day portfolio management, their presence on the board likely strengthens sourcing for fund commitments and co-investment opportunities.

The Mount Sinai Hospital Foundation and the Mount Sinai Children's Center Foundation serve as the primary philanthropic vehicles. They receive major gifts—including the Dubins' funding of the Dubin Breast Center—and operate alongside the endowment. Gift acceptance and grant-making processes are governed separately from investment-office decisions.

Mount Sinai has not publicly disclosed explicit exclusions. Given its non-profit status, leveraged buyout strategies that create unrelated business taxable income may face structural limitations. The endowment is also unlikely to invest in tobacco, firearms, or private-prison operators consistent with standard academic medical center policies, though no formal restricted list has been published.